Diagnosis of COVID-19, vitality of emerging technologies and preventive measures

作者: Fei Xiao , Yimin Sun , Yun Xu , Muhammad Asif

DOI: 10.1016/J.CEJ.2021.130189

关键词: VitalityPoint-of-care testingBusinessPoint of carePublic healthRisk analysis (engineering)DiseaseIsolation (health care)GovernmentEmerging technologies

摘要: Coronavirus diseases-2019 (COVID-19) is becoming increasing serious and major threat to public health concerns. As a matter of fact, timely testing enhances the life-saving judgments …

参考文章(203)
Xinjin Liu, Jiangpeng Feng, Qiuhan Zhang, Dong Guo, Lu Zhang, Tao Suo, Wenjia Hu, Ming Guo, Xin Wang, Zhixiang Huang, Yong Xiong, Guozhong Chen, Yu Chen, Ke Lan, Analytical comparisons of SARS-COV-2 detection by qRT-PCR and ddPCR with multiple primer/probe sets. Emerging microbes & infections. ,vol. 9, pp. 1175- 1179 ,(2020) , 10.1080/22221751.2020.1772679
Giuseppina La Rosa, Marcello Iaconelli, Pamela Mancini, Giusy Bonanno Ferraro, Carolina Veneri, Lucia Bonadonna, Luca Lucentini, Elisabetta Suffredini, First detection of SARS-CoV-2 in untreated wastewaters in Italy Science of The Total Environment. ,vol. 736, pp. 139652- 139652 ,(2020) , 10.1016/J.SCITOTENV.2020.139652
J. Van Elslande, E. Houben, M. Depypere, A. Brackenier, S. Desmet, E. André, M. Van Ranst, K. Lagrou, P. Vermeersch, Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients. Clinical Microbiology and Infection. ,vol. 26, pp. 1082- 1087 ,(2020) , 10.1016/J.CMI.2020.05.023
Jane Ru Choi, Development of Point-of-Care Biosensors for COVID-19 Frontiers in Chemistry. ,vol. 8, pp. 517- ,(2020) , 10.3389/FCHEM.2020.00517
Henry T Greely, COVID-19 Immunity Certificates: Science, Ethics, Policy, and Law Journal of Law and the Biosciences. ,vol. 7, ,(2020) , 10.1093/JLB/LSAA035
Niko Kohmer, Sandra Westhaus, Cornelia Rühl, Sandra Ciesek, Holger F. Rabenau, Clinical performance of different SARS-CoV-2 IgG antibody tests. Journal of Medical Virology. ,vol. 92, pp. 2243- 2247 ,(2020) , 10.1002/JMV.26145
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, David R Martinez, Rajendra Raut, Alena J Markmann, Caleb Cornaby, Luther Bartelt, Susan Weiss, Yara Park, Caitlin E Edwards, Eric Weimer, Erin M Scherer, Nadine Rouphael, Srilatha Edupuganti, Daniela Weiskopf, Longping V Tse, Yixuan J Hou, David Margolis, Alessandro Sette, Matthew H Collins, John Schmitz, Ralph S Baric, Aravinda M de Silva, None, The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. Science immunology. ,vol. 5, ,(2020) , 10.1126/SCIIMMUNOL.ABC8413
Noton K. Dutta, Kaushiki Mazumdar, James T. Gordy, The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development. Journal of Virology. ,vol. 94, ,(2020) , 10.1128/JVI.00647-20